Is Fortress Biotech Stock a Good Investment?
Fortress Biotech Investment Advice | FBIO |
- Examine Fortress Biotech's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Fortress Biotech's leadership team and their track record. Good management can help Fortress Biotech navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Fortress Biotech's business and its evolving consumer preferences.
- Compare Fortress Biotech's performance and market position to its competitors. Analyze how Fortress Biotech is positioned in terms of product offerings, innovation, and market share.
- Check if Fortress Biotech pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Fortress Biotech's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Fortress Biotech stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Fortress Biotech is a good investment.
Sell | Buy |
Sell
Market Performance | Very Weak | Details | |
Volatility | Somewhat reliable | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Strong Buy | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine Fortress Biotech Stock
Researching Fortress Biotech's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 25.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.52. Some equities with similar Price to Book (P/B) outperform the market in the long run. Fortress Biotech recorded a loss per share of 5.74. The entity had not issued any dividends in recent years. The firm had 1:15 split on the 10th of October 2023.
To determine if Fortress Biotech is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Fortress Biotech's research are outlined below:
| Fortress Biotech generated a negative expected return over the last 90 days | |
| Fortress Biotech may become a speculative penny stock | |
| Fortress Biotech has high historical volatility and very poor performance | |
| Fortress Biotech has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 84.51 M. Net Loss for the year was (60.64 M) with loss before overhead, payroll, taxes, and interest of (85.66 M). | |
| Fortress Biotech currently holds about 208.35 M in cash with (128.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.92, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Fortress Biotech has a frail financial position based on the latest SEC disclosures | |
| Roughly 25.0% of the company shares are held by company insiders | |
| Latest headline from simplywall.st: Fortress Biotech Insiders Placed Bullish Bets Worth US3.08m |
Fortress Biotech Quarterly Long Term Debt |
|
Fortress Biotech uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Fortress Biotech. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Fortress Biotech's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 20th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 4th of April 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Earnings surprises can significantly impact Fortress Biotech's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Fortress Biotech's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2015-08-10 | 2015-06-30 | -0.14 | -0.12 | 0.02 | 14 | ||
2022-08-11 | 2022-06-30 | -0.21 | -0.24 | -0.03 | 14 | ||
2020-05-11 | 2020-03-31 | -0.23 | -0.19 | 0.04 | 17 | ||
2020-03-16 | 2019-12-31 | -0.31 | -0.27 | 0.04 | 12 | ||
2013-08-05 | 2013-06-30 | -0.34 | -0.38 | -0.04 | 11 | ||
2013-03-14 | 2012-12-31 | -0.28 | -0.32 | -0.04 | 14 | ||
2012-11-14 | 2012-09-30 | -0.28 | -0.24 | 0.04 | 14 | ||
2012-05-15 | 2012-03-31 | -0.31 | -0.35 | -0.04 | 12 |
Know Fortress Biotech's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Fortress Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fortress Biotech backward and forwards among themselves. Fortress Biotech's institutional investor refers to the entity that pools money to purchase Fortress Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | National Asset Management Inc | 2023-12-31 | 86 K | Blackrock Inc | 2023-12-31 | 74.9 K | Envestnet Asset Management Inc | 2023-12-31 | 62.4 K | Geode Capital Management, Llc | 2023-12-31 | 56.7 K | Commonwealth Equity Services Inc | 2023-12-31 | 53.1 K | Advisor Group Holdings, Inc. | 2023-12-31 | 39.4 K | Rsm Us Wealth Management Llc | 2023-12-31 | 36.2 K | Jane Street Group, Llc | 2023-12-31 | 28.2 K | Renaissance Technologies Corp | 2023-12-31 | 25.9 K | Cvi Holdings Llc | 2023-12-31 | 764.5 K | Nantahala Capital Management, Llc | 2023-12-31 | 745.1 K |
Fortress Biotech's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 34.26 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Fortress Biotech's market, we take the total number of its shares issued and multiply it by Fortress Biotech's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Market Cap |
|
Fortress Biotech's profitablity analysis
Fortress Biotech's profitability indicators refer to fundamental financial ratios that showcase Fortress Biotech's ability to generate income relative to its revenue or operating costs. If, let's say, Fortress Biotech is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Fortress Biotech's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Fortress Biotech's profitability requires more research than a typical breakdown of Fortress Biotech's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.41) | (0.43) | |
| Return On Capital Employed | (1.69) | (1.77) | |
| Return On Assets | (0.36) | (0.38) | |
| Return On Equity | (2.69) | (2.82) |
Determining Fortress Biotech's profitability involves analyzing its financial statements and using various financial metrics to determine if Fortress Biotech is a good buy. For example, gross profit margin measures Fortress Biotech's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Fortress Biotech's profitability and make more informed investment decisions.
The data published in Fortress Biotech's official financial statements usually reflect Fortress Biotech's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Fortress Biotech. For example, before you start analyzing numbers published by Fortress accountants, it's critical to develop an understanding of what Fortress Biotech's liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Fortress Biotech's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Fortress Biotech's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Fortress Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Fortress Biotech. Please utilize our Beneish M Score to check the likelihood of Fortress Biotech's management manipulating its earnings.
Evaluate Fortress Biotech's management efficiency
Fortress Biotech has return on total asset (ROA) of (0.3413) % which means that it has lost $0.3413 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.3964) %, meaning that it created substantial loss on money invested by shareholders. Fortress Biotech's management efficiency ratios could be used to measure how well Fortress Biotech manages its routine affairs as well as how well it operates its assets and liabilities. As of the 31st of May 2024, Return On Tangible Assets is likely to drop to -0.43. In addition to that, Return On Capital Employed is likely to drop to -1.77. At this time, Fortress Biotech's Asset Turnover is very stable compared to the past year.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 2.78 | 2.64 | |
| Net Current Asset Value | 0.00 | 0.00 | |
| Tangible Asset Value | 0.00 | 0.00 | |
| Tangible Book Value Per Share | (2.31) | (2.19) | |
| Enterprise Value Over EBITDA | (0.24) | (0.26) | |
| Price Book Value Ratio | 1.08 | 1.03 | |
| Enterprise Value Multiple | (0.24) | (0.26) | |
| Price Fair Value | 1.08 | 1.03 | |
| Enterprise Value | 32.1 M | 53.6 M |
The analysis of Fortress Biotech's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Fortress Biotech's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Fortress Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta 1.55 |
Basic technical analysis of Fortress Stock
As of the 31st of May, Fortress Biotech shows the Variance of 22.08, standard deviation of 4.7, and Mean Deviation of 3.15. Fortress Biotech technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to collect and analyze data for thirteen technical drivers for Fortress Biotech, which can be compared to its peers. Please confirm Fortress Biotech market risk adjusted performance, variance, as well as the relationship between the Variance and value at risk to decide if Fortress Biotech is priced favorably, providing market reflects its regular price of 1.84 per share. Please also check Fortress Biotech jensen alpha, which is currently at (0.05) to verify the company can sustain itself at a future point.Fortress Biotech's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Fortress Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Fortress Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Fortress Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Understand Fortress Biotech's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing Fortress Biotech's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0068 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 3.15 | |||
| Coefficient Of Variation | (31,239) | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.08 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.13) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 24.66 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 10.1 | |||
| Skewness | 1.55 | |||
| Kurtosis | 3.69 |
| Risk Adjusted Performance | 0.0068 | |||
| Market Risk Adjusted Performance | (0.01) | |||
| Mean Deviation | 3.15 | |||
| Coefficient Of Variation | (31,239) | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.08 | |||
| Information Ratio | (0.01) | |||
| Jensen Alpha | (0.05) | |||
| Total Risk Alpha | (0.13) | |||
| Treynor Ratio | (0.02) | |||
| Maximum Drawdown | 24.66 | |||
| Value At Risk | (5.76) | |||
| Potential Upside | 10.1 | |||
| Skewness | 1.55 | |||
| Kurtosis | 3.69 |
Consider Fortress Biotech's intraday indicators
Fortress Biotech intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Fortress Biotech stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 5501.2 | |||
| Daily Balance Of Power | 0.0909 | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 1.87 | |||
| Day Typical Price | 1.86 | |||
| Price Action Indicator | (0.02) | |||
| Period Momentum Indicator | 0.01 |
Fortress Stock media impact
Far too much social signal, news, headlines, and media speculation about Fortress Biotech that are available to investors today. That information is available publicly through Fortress media outlets and privately through word of mouth or via Fortress internal channels. However, regardless of the origin, that massive amount of Fortress data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Fortress Biotech news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Fortress Biotech relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Fortress Biotech's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Fortress Biotech alpha.
Fortress Biotech Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Fortress Biotech can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Fortress Biotech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Fortress Biotech Corporate Management
Elected by the shareholders, the Fortress Biotech's board of directors comprises two types of representatives: Fortress Biotech inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Fortress. The board's role is to monitor Fortress Biotech's management team and ensure that shareholders' interests are well served. Fortress Biotech's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Fortress Biotech's outside directors are responsible for providing unbiased perspectives on the board's policies.
| George Avgerinos | Sr. VP of Biologics Operations | Profile | |
| Samuel Berry | General Secretary | Profile | |
| Robyn Hunter | Ex Officer | Profile | |
| Thomas Schaible | Project Disease | Profile |
How to buy Fortress Stock?
To provide specific investment advice or recommendations on Fortress Biotech stock, we recommend investors consider the following general factors when evaluating Fortress Biotech. This will help you to make an informed decision on whether to include Fortress Biotech in one of your diversified portfolios:- Examine Fortress Biotech's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research Fortress Biotech's leadership team and their track record. Good management can help Fortress Biotech navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Biotechnology space and any emerging trends that could impact Fortress Biotech's business and its evolving consumer preferences.
- Compare Fortress Biotech's performance and market position to its competitors. Analyze how Fortress Biotech is positioned in terms of product offerings, innovation, and market share.
- Check if Fortress Biotech pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about Fortress Biotech's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Fortress Biotech stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Fortress Biotech is a good investment.
Already Invested in Fortress Biotech?
The danger of trading Fortress Biotech is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Fortress Biotech is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Fortress Biotech. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Fortress Biotech is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Fortress Biotech offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Fortress Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Fortress Biotech Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Fortress Biotech Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Complementary Tools for Fortress Stock analysis
When running Fortress Biotech's price analysis, check to measure Fortress Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fortress Biotech is operating at the current time. Most of Fortress Biotech's value examination focuses on studying past and present price action to predict the probability of Fortress Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fortress Biotech's price. Additionally, you may evaluate how the addition of Fortress Biotech to your portfolios can decrease your overall portfolio volatility.
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is Fortress Biotech's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.74) | Revenue Per Share 7.954 | Quarterly Revenue Growth 0.048 | Return On Assets (0.34) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Fortress Biotech's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.